These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21127840)

  • 1. Evaluation of FRAX to characterise fracture risk in Poland.
    Czerwinski E; Kanis JA; Osieleniec J; Kumorek A; Milert A; Johansson H; McCloskey EV; Gorkiewicz M
    Osteoporos Int; 2011 Sep; 22(9):2507-12. PubMed ID: 21127840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture Risk Indices From DXA-Based Finite Element Analysis Predict Incident Fractures Independently From FRAX: The Manitoba BMD Registry.
    Leslie WD; Luo Y; Yang S; Goertzen AL; Ahmed S; Delubac I; Lix LM
    J Clin Densitom; 2019; 22(3):338-345. PubMed ID: 30852033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fracture risk prediction in outpatients from Krakow Region using FRAX tool versus fracture risk in 11-year follow-up.
    Czerwiński E; Borowy P; Kumorek A; Amarowicz J; Górkiewicz M; Milert A
    Ortop Traumatol Rehabil; 2013; 15(6):617-28. PubMed ID: 24662908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
    Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
    Osteoporos Int; 2011 Dec; 22(12):3037-45. PubMed ID: 21279504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.
    Ettinger B; Ensrud KE; Blackwell T; Curtis JR; Lapidus JA; Orwoll ES;
    Osteoporos Int; 2013 Apr; 24(4):1185-93. PubMed ID: 23179575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model.
    Issayeva S; Lesnyak O; Zakroyeva A; Issayeva B; Dilmanova D; Johansson H; Liu E; Lorentzon M; Harvey NC; McCloskey E; Kanis JA
    Arch Osteoporos; 2020 Feb; 15(1):30. PubMed ID: 32108270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.
    Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD;
    Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated fracture incidence rates for the Italian version of FRAX®.
    Piscitelli P; Chitano G; Johannson H; Brandi ML; Kanis JA; Black DM
    Osteoporos Int; 2013 Mar; 24(3):859-66. PubMed ID: 22638710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
    Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
    BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model.
    Zakroyeva A; Lesnyak O; Cazac V; Groppa L; Russu E; Chislari L; Rotaru L; Johansson H; Harvey NC; McCloskey E; Lorentzon M; Kanis JA
    Arch Osteoporos; 2020 Jan; 15(1):13. PubMed ID: 31993755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
    Yu R; Leung J; Woo J
    J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort.
    González-Macías J; Marin F; Vila J; Díez-Pérez A
    Bone; 2012 Jan; 50(1):373-7. PubMed ID: 22129640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?
    Leslie WD; Morin SN; Lix LM; Majumdar SR
    Osteoporos Int; 2014 Dec; 25(12):2817-24. PubMed ID: 25092059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease.
    Whitlock RH; Leslie WD; Shaw J; Rigatto C; Thorlacius L; Komenda P; Collister D; Kanis JA; Tangri N
    Kidney Int; 2019 Feb; 95(2):447-454. PubMed ID: 30579724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.
    Lalmohamed A; Welsing PM; Lems WF; Jacobs JW; Kanis JA; Johansson H; De Boer A; De Vries F
    Osteoporos Int; 2012 Mar; 23(3):861-9. PubMed ID: 22120910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating osteoporotic fracture risk with the Fracture Risk Assessment Tool in Chinese patients with rheumatoid arthritis.
    Meng J; Li Y; Yuan X; Lu Y
    Medicine (Baltimore); 2017 May; 96(18):e6677. PubMed ID: 28471962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the FRAX predictive model for major osteoporotic fracture in a historical cohort of Spanish women.
    Tebé Cordomí C; Del Río LM; Di Gregorio S; Casas L; Estrada MD; Kotzeva A; Espallargues M
    J Clin Densitom; 2013; 16(2):231-7. PubMed ID: 22748778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidance for the adjustment of FRAX according to the dose of glucocorticoids.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Osteoporos Int; 2011 Mar; 22(3):809-16. PubMed ID: 21229233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the FRAX model for hip fracture predictions in the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE).
    Sund R; Honkanen R; Johansson H; Odén A; McCloskey E; Kanis J; Kröger H
    Calcif Tissue Int; 2014 Jul; 95(1):39-45. PubMed ID: 24792689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.